Monthly Archives: December 2018

The Estée Lauder Companies Inc (EL) Receives a Buy from Piper Jaffray

In a report released today, Erinn Murphy from Piper Jaffray reiterated a Buy rating on The Estée Lauder Companies Inc (EL – Research Report), with a price target of $151. The company’s shares opened today at $130.10. According to TipRanks.com,

The President & CEO of Barnwell Industries (NYSE: BRN) is Buying Shares

Today, the President & CEO of Barnwell Industries (BRN – Research Report), Alexander Kinzler, bought shares of BRN for $7,650. This recent transaction increases Alexander Kinzler’s holding in the company by 1.54% to a total of $457.3K. In addition to

Amyris (AMRS) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Amyris (AMRS – Research Report) today and set a price target of $11. The company’s shares opened today at $3.85, close to its 52-week low of $2.92. Dayal observed: “We

Heron Therapeutics (HRTX) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Brandon Folkes reiterated a Buy rating on Heron Therapeutics (HRTX – Research Report) today and set a price target of $50. The company’s shares opened today at $25.41. Folkes observed: “We reiterate our OW rating and expect

RedHill Biopharma (RDHL) Receives a Buy from WBB Securities

RedHill Biopharma (RDHL – Research Report) received a Buy rating and a $9 price target from WBB Securities analyst Stephen Brozak today. The company’s shares closed on Friday at $5.36, close to its 52-week low of $4.40. According to TipRanks.com,

Evolent Health (EVH) Receives a Rating Update from a Top Analyst

Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of $37. The company’s shares closed on Friday at $19.71. Halper said: “We reaffirm our Overweight rating and